Repigra Tablets | Trioxsalen 25mg for Vitiligo & Repigmentation Therapy

Repigra Tablets contain Trioxsalen, a photosensitizing agent used in PUVA (Psoralen + UVA) therapy for the treatment of vitiligo and other depigmenting skin disorders. When activated by controlled UVA exposure, it stimulates melanocyte activity and promotes melanin production in affected areas.

Repigra helps restore natural skin color gradually, improving cosmetic appearance and confidence. It is typically used under dermatological supervision as part of a structured treatment plan.

🔹 Key Benefits

• Promotes repigmentation in vitiligo

• Stimulates melanocyte activity and melanin production

• Supports gradual restoration of natural skin tone

• Effective as part of PUVA therapy

• Improves cosmetic appearance and patient confidence

🔹 Indications

• Vitiligo

• Psoriasis (as PUVA therapy)

• Cutaneous T-cell lymphoma (as advised)

• Other dermatological conditions requiring PUVA therapy